CN104276960A - 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 - Google Patents

盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 Download PDF

Info

Publication number
CN104276960A
CN104276960A CN201410500983.5A CN201410500983A CN104276960A CN 104276960 A CN104276960 A CN 104276960A CN 201410500983 A CN201410500983 A CN 201410500983A CN 104276960 A CN104276960 A CN 104276960A
Authority
CN
China
Prior art keywords
celecoxib
eutectic
tapentadol hydrochloride
pain
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410500983.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN104276960B (zh
Inventor
徐奎
刘丽
刘经星
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Heal Star Pharmaceutical Co.,Ltd.
Original Assignee
Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd filed Critical Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd
Priority to CN201410500983.5A priority Critical patent/CN104276960B/zh
Publication of CN104276960A publication Critical patent/CN104276960A/zh
Application granted granted Critical
Publication of CN104276960B publication Critical patent/CN104276960B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

CN201410500983.5A 2014-09-26 2014-09-26 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法 Active CN104276960B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410500983.5A CN104276960B (zh) 2014-09-26 2014-09-26 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410500983.5A CN104276960B (zh) 2014-09-26 2014-09-26 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法

Publications (2)

Publication Number Publication Date
CN104276960A true CN104276960A (zh) 2015-01-14
CN104276960B CN104276960B (zh) 2016-09-28

Family

ID=52252364

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410500983.5A Active CN104276960B (zh) 2014-09-26 2014-09-26 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法

Country Status (1)

Country Link
CN (1) CN104276960B (it)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107595792A (zh) * 2017-11-06 2018-01-19 刘丽 一种盐酸他喷他多塞来昔布片剂及其制备方法
CN112807315A (zh) * 2021-01-18 2021-05-18 江苏谛奇医药科技有限公司 塞来昔布和盐酸他喷他多低共熔混合物、含其的药物组合物及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050277687A1 (en) * 2002-11-22 2005-12-15 Gruenenthal Gmbh Combination of selected analgesics and COX-II inhibitors
WO2009067706A1 (en) * 2007-11-21 2009-05-28 Oxigene, Inc. Method for treating hematopoietic neoplasms
CN102036946A (zh) * 2008-05-21 2011-04-27 埃斯蒂文博士实验室股份有限公司 用于治疗疼痛的度洛西汀和Cox-抑制剂的共晶体
CN102188365A (zh) * 2011-05-11 2011-09-21 中山大学 一种难溶性药物共晶固体分散体及其制备方法
WO2011151080A1 (en) * 2010-06-04 2011-12-08 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050277687A1 (en) * 2002-11-22 2005-12-15 Gruenenthal Gmbh Combination of selected analgesics and COX-II inhibitors
US20130109733A1 (en) * 2002-11-22 2013-05-02 Gruenenthal Gmbh Combination of Selected Analgesics and Cox-II Inhibitors
WO2009067706A1 (en) * 2007-11-21 2009-05-28 Oxigene, Inc. Method for treating hematopoietic neoplasms
CN102036946A (zh) * 2008-05-21 2011-04-27 埃斯蒂文博士实验室股份有限公司 用于治疗疼痛的度洛西汀和Cox-抑制剂的共晶体
WO2011151080A1 (en) * 2010-06-04 2011-12-08 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical compositions of co-crystals of tramadol and coxibs
CN102188365A (zh) * 2011-05-11 2011-09-21 中山大学 一种难溶性药物共晶固体分散体及其制备方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
PRZYBYLAK,KATARZYNA R. 等: "How Does the Quality of Phospholipidosis Data Influence the Predictivity of Structural Alerts?", 《JOURNAL OF CHEMICAL INFORMATION AND MODELING》, vol. 54, no. 8, 25 July 2014 (2014-07-25), pages 2224 - 2232, XP 008178071, DOI: doi:10.1021/ci500233k *
SLAVOV,SVETOSLAV H. 等: "Computational identification of a phospholipidosis toxicophore using 13C and 15N NMR-distance based fingerprints", 《BIOORGANIC & MEDICINAL CHEMISTRY》, vol. 22, no. 23, 27 August 2014 (2014-08-27), pages 6706 - 6714 *
张正之 等: "新的晶体生长方法-共结晶化", 《化学通报》, no. 4, 1 May 1990 (1990-05-01), pages 18 - 19 *
许喜林 等: "共结晶技术和应用", 《甘蔗糖业》, no. 6, 25 December 2000 (2000-12-25), pages 33 - 36 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107595792A (zh) * 2017-11-06 2018-01-19 刘丽 一种盐酸他喷他多塞来昔布片剂及其制备方法
CN112807315A (zh) * 2021-01-18 2021-05-18 江苏谛奇医药科技有限公司 塞来昔布和盐酸他喷他多低共熔混合物、含其的药物组合物及其制备方法和应用

Also Published As

Publication number Publication date
CN104276960B (zh) 2016-09-28

Similar Documents

Publication Publication Date Title
US10377757B2 (en) Crystal form of JAK inhibitor and preparation method thereof
CN102344408B (zh) 双效麻醉药物
CN103864760A (zh) 一种盐酸法舒地尔化合物
CN108530425A (zh) 一种尼拉帕尼对甲苯磺酸盐水合物晶型及其制备方法
US20140275137A1 (en) Tetrandrine family pharmaceutical formulations and method
CN104276960A (zh) 盐酸他喷他多和塞来昔布共晶及其组合物和制备方法
CN102266343A (zh) 供注射用盐酸法舒地尔药物组合物
CN101331112B (zh) 一种联苯乙酸盐及其制备方法与应用
CN104447682A (zh) 比拉斯汀化合物
CN106511264A (zh) 一种盐酸哌甲酯口服溶液剂及其制备方法
CN102659905B (zh) 一种常春藤皂苷元衍生物及其制备方法和应用
US10266523B2 (en) Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereof
CN101669929A (zh) 一种布洛芬液体制剂的制备方法及其用途
CN105503888B (zh) 一种盐酸纳洛酮晶型化合物
CN105399719B (zh) 一种伪麻黄碱类衍生物及其制备方法与应用
WO2021160134A1 (zh) 3-芳氧基-3-五元杂芳基-丙胺类化合物的制备方法及晶型
WO2022001889A1 (zh) 去甲曲马多的盐及其用途
CN105037180A (zh) 一种双重作用的中枢性镇痛新化合物、制备方法及用途
CN103288821A (zh) 巴马亭衍生物及其制备方法与应用
CN102283824B (zh) 一种治疗感冒的药物组合物及软胶囊制剂
CN102786462B (zh) 阿比朵尔盐酸盐晶b型及制法与在药品和保健品中应用
CN105315230A (zh) 无定型形态的匹维溴铵
CN105439889A (zh) 一种香兰素胺类新化合物、其制备方法及医药用途
CN104876942A (zh) 单硝酸异山梨酯半水化合物
CN103830169A (zh) 一种盐酸法舒地尔注射液及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20190203

Address after: 230000 No. 15 Weiwu Road, Baohe Industrial Zone, Hefei City, Anhui Province

Patentee after: Anhui Heal Star Pharmaceutical Co.,Ltd.

Address before: 230051 No. 15 Yan'an Road, Baohe Industrial Zone, Hefei City, Anhui Province

Patentee before: Anhui Province Yi Xinming Pharmaceutical Technology Co., Ltd

TR01 Transfer of patent right